Vertex Corp. is a prominent player in the biotechnology sector, specifically focusing on the research, development, and commercialization of transformative therapies for serious diseases. Known for it... Vertex Corp. is a prominent player in the biotechnology sector, specifically focusing on the research, development, and commercialization of transformative therapies for serious diseases. Known for its cutting-edge approach in the realm of genetic therapies, Vertex has made significant strides in treating cystic fibrosis, a life-threatening genetic disorder. The company’s innovative drug portfolio caters to unmet medical needs, often pushing boundaries in medical research and development. With strategic research centers located globally, Vertex Corp. collaborates extensively with academic, industry, and healthcare partners to enhance the development pipeline. This commitment to cultivating a robust research ecosystem underscores its market significance. By continually seeking advancements in medicine, Vertex plays a crucial role in the healthcare landscape, impacting not just the life sciences industry but also the broader pharmaceutical market.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Vertex is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Vertex is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Vertex's data?

Start your 30-day free trial to request a data review for Vertex.

Start Free Trial

Legal Center Contact Us